B. Huntly
Molecular Biology · 2004–2016
A researcher in the Science corpus: 8 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 84 citations into it
Whom B. Huntly trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts B. Huntly overall
Papers from B. Huntly's perspective
Ordered by how strongly the researchers B. Huntly trusts endorse each paper. Same corpus, a different order for every researcher.
- Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells (Nature)
- Identification of human brain tumour initiating cells (Nature)
- Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity (Nature Immunology)
- The Hallmarks of Cancer Review
- Identification of a cancer stem cell in human brain tumors. (Cancer Research)
- Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro. (Blood)
- Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. (New England Journal of Medicine)
- Biology of hematopoietic stem cells and progenitors: implications for clinical application. (Annual Review of Immunology)
- The origin and evolution of mutations in Acute Myeloid Leukemia (Cell)
- Self-renewal, multipotency, and the existence of two cell populations within an epithelial stem cell niche. (Cell)
Their papers
- Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia (2011) — 1,525 citations
- MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. (2004) — 754 citations
- A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia (2016) — 609 citations
- Leukaemia stem cells and the evolution of cancer-stem-cell research (2005) — 654 citations
- Cancer stem cell definitions and terminology: the devil is in the details (2012) — 694 citations
- Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2 (2013) — 1,750 citations
- Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. (2005) — 3,130 citations
- Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl. (2005) — 1,536 citations